Back to MW MARSHALL WACE, LLP

ANVSANVS
Showing 5 of 9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ANNOVIS BIO INC

Yes. Marshall Wace holds 1,842,339 shares of ANVS (Annovis Bio), worth $3.4M, as of its Q2 2026 13F filing. It increased the position by 654,840 shares (+55.1%) from Q1 2026. Marshall Wace has held ANVS since Q4 2025, across 3 quarterly 13F filings.

Current Value

$3.4M

Current Shares

1.8M

Total Value Change

+$3.2M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+55.1%
$3.4M0.0%$1.86
37
2026-Q1
Increased
1.2M
+63.6%
$2.6M0.0%$2.58
38
2025-Q4
New
725,862
-
$2.5M0.0%$3.46
36
2025-Q3
Exited
0
-100.0%
$00.0%$2.04
0
2025-Q2
New
90,907
-
$197,2680.0%$2.05
32

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used